News

Currently, Mr Crotty is managing partner of CroBern Management Partnership, a healthcare investment and advisory firm. Previously, he served as president and CEO of CroBern, a healthcare consulting

Natus has also granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock to cover over-allotments, if any. The offering

The cooperative research and development agreement with the National Institutes of Health (NIH) gives Amsterdam Molecular Therapeutics (AMT) the option to license the exclusive rights to the recombinant

Under the terms of the agreement, JapanBridge has agreed to pay ProStrakan more than $26 million in upfront and milestone payments, subject to the achievement of certain approvals

The closing of the offering is expected to take place on May 29, 2008, subject to the satisfaction of customary closing conditions. The company has granted the underwriters

The state-of-the-art aortic endograft is designed for thoracic endovascular aortic repair (TEVAR), a minimally invasive alternative to traditional, open surgery. The Zenith TX2 is indicated to treat patients

The placement will be in the form of units, each of which will be comprised of one common share in the company and one share purchase warrant. Each

The new Dor UK office gives Dor a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based

New Cigna members from the State of Georgia will be able to receive in-patient and out-patient services from an expanded and comprehensive network inclusive of 147 hospitals and